PRUFIBRY
LIVE

Serial Number

79406268

Owner

Biotest AG

Attorney

Garth M. Dahlen

Filing Date

Apr 12, 2024

Add to watchlist:

No watchlists yet
View on USPTO

PRUFIBRY Trademark

Serial Number: 79406268 • Registration: 7924146

PRUFIBRY is a trademark filed by Biotest AG on April 12, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Biotest AG

Landsteinerstraße 5

Entity Type: 25

Trademark Details

Filing Date

April 12, 2024

Registration Date

September 2, 2025

Published for Opposition

July 15, 2025

Goods & Services

Biological preparations for use in industry and science, namely proteins and protein preparations derived from human blood, blood plasma, or blood serum, coagulation factors; biological preparations, namely plasma and serum preparations for cultivating cells, tissue, or organs for industrial and scientific purposes.

Pharmaceutical, medical and veterinary preparations for hematology, for intensive care medicine, for transplantation medicine, for oncology, for influencing blood diseases, and for influencing blood coagulation; blood products, blood substitute, and blood plasma substitute for medical purposes; blood serums preparations for medical purposes, in particular those containing serum proteins and related solutions; pharmaceutical proteins and medical protein preparations made from human blood, blood plasma and blood serum for hematology, for intensive care medicine, for transplantation medicine, for oncology, for influencing blood diseases, and for influencing blood coagulation; pharmaceutical preparations in the nature of human coagulation factors for hematology, for intensive care medicine, for transplantation medicine, for the treatment of oncology, for influencing blood diseases, and for influencing blood coagulation; fibrinogen and fibrinogen made from human blood plasma, in the nature of pharmaceutical preparations for hematology, for intensive care medicine, for transplantation medicine, for the treatment of oncology, for influencing blood diseases, and for influencing blood coagulation; pharmaceutical and veterinary products for hematology, intensive care medicine, transplantation medicine, oncology, for influencing blood diseases, and for influencing blood coagulation

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 9, 2026 FINO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 26, 2026 OPNX
FINAL DISPOSITION NOTICE SENT TO IB
Mar 19, 2026 FICS
FINAL DISPOSITION PROCESSED
Mar 19, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 9, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 9, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 2, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 2, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 2, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 15, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 15, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 9, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 11, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 11, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 11, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 11, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 11, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 17, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 17, 2025 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 17, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 17, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 17, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 17, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 17, 2025 COAR
REFUSAL PROCESSED BY IB
Nov 17, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 30, 2024 RFCS
REFUSAL PROCESSED BY MPU
Oct 30, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 25, 2024 RFCR
NON-FINAL ACTION WRITTEN
Oct 24, 2024 CNRT
ASSIGNED TO EXAMINER
Oct 17, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 11, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 11, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 10, 2024 REPR